Cannabis News

Hexo Corp.'s chief executive says he's seen a "price war" take shape over the last five months that could cause "significant" damage to Canada's cannabis industry. "No one wins in a price war," Charlie Bowman told analysts on a Friday call.

SANTA ANA, Calif. (AP) — An inmate who organized a daring, elaborate Southern California jailbreak in 2016 was found guilty Thursday of the escape but acquitted of kidnapping a taxi driver while on the run, authorities said.

FRANKFORT, Ky. (AP) — The Kentucky Senate voted Thursday to legalize medical marijuana in the state, delivering a breakthrough endorsement after years of resisting access to cannabis for people suffering from a series of debilitating illnesses.

TOPEKA, Kan. (AP) — Kansas legislators aren't likely to legalize marijuana for medical uses this year following a vote Thursday.

RCMP in British Columbia announced Thursday the results of two drug investigations they say disrupted major organized crime groups that are flooding the streets with toxic drugs involving "transnational" drug production and distribution operations.

GATINEAU, Que. — Hexo Corp. reported a net loss of $11.1 million in its latest quarter, up from a year earlier, when it reported a loss of $690.3 million, which included $616 million in one-time impairment charges. The Gatineau, Que.

MONTREAL — A new private equity firm based in Ottawa says it has acquired the company behind one of the world's largest pornography sites, Pornhub.

ALBANY, N.Y. (AP) — A coalition that includes some of New York's medical marijuana companies sued state cannabis regulators Thursday in an effort to open up licensing to all retail dispensary applicants immediately.

LOS ANGELES (AP) — Eight children were sickened at a Los Angeles school on Wednesday after eating marijuana gummies, authorities said. Paramedics were called to Sun Valley Magnet School shortly before 1:30 p.m.

Many older adults are using medical marijuana to treat a variety of conditions, but experts say that conflicting laws, unclear safety standards and complicated rulemaking processes mean it could be years before Medicare may cover the drug.